Treating primary aldosteronism-induced hypertension: novel approaches and future outlooks
Primary aldosteronism (PA) is the most common cause of secondary hypertension and is
associated with increased morbidity and mortality when compared with blood pressure …
associated with increased morbidity and mortality when compared with blood pressure …
Associations between primary aldosteronism and diabetes, poor bone health, and sleep apnea—what do we know so far?
Primary aldosteronism (PA), the most common cause of secondary hypertension, is a well-
recognized condition that can lead to cardiovascular and renal complications. PA is …
recognized condition that can lead to cardiovascular and renal complications. PA is …
Eligibility for percutaneous renal denervation: the importance of a systematic screening
Objective: Percutaneous renal denervation (pRDN) is a new and promising therapy for
resistant hypertension. Among patients suspected of having resistant hypertension, the …
resistant hypertension. Among patients suspected of having resistant hypertension, the …
The effect of vitamin D treatment on clinical and biochemical outcomes of primary aldosteronism
NA Ismail, NA Kamaruddin, S Azhar Shah… - Clinical …, 2020 - Wiley Online Library
Introduction Primary aldosteronism (PA) contributed to the cardiovascular disease and
metabolic alterations independent of the blood pressure level. Evidence exists that …
metabolic alterations independent of the blood pressure level. Evidence exists that …
[HTML][HTML] Desenvolvimento e validação de um método analítico por espectrofotometria UV para quantificação de carvedilol
PAA Borba, MK Riekes, RN Pereira, HK Stulzer… - Química …, 2013 - SciELO Brasil
This paper reports the development and validation of a new analytical method using UV
spectrophotometry to quantify carvedilol (CRV) in hydrophilic matrices and raw material …
spectrophotometry to quantify carvedilol (CRV) in hydrophilic matrices and raw material …
[HTML][HTML] Multimodality imaging in patients with secondary hypertension: with a focus on appropriate imaging approaches depending on the etiologies
H Ahn, EJ Chun, HJ Lee, SI Hwang… - Korean Journal of …, 2018 - synapse.koreamed.org
Although the causes of hypertension are usually unknown, about 10% of the cases occur
secondary to specific etiologies, which are often treatable. Common categories of secondary …
secondary to specific etiologies, which are often treatable. Common categories of secondary …
Primary hyperaldosteronism is associated with increased mortality and morbidity in patients with hypertension and diabetes
Aims Primary hyperaldosteronism (PA) is a common cause of hypertension. It is more
prevalent in patients with diabetes. We assessed the cardiovascular impact of PA in patients …
prevalent in patients with diabetes. We assessed the cardiovascular impact of PA in patients …
Pharmaceutical approaches involving carvedilol characterization, compatibility with different excipients and kinetic studies
PAA Borba, DD Vecchia, MK Riekes… - Journal of thermal …, 2014 - Springer
This study was performed to investigate the physical–chemical characteristics of carvedilol
(CRV), complemented by compatibility studies with a great variety of pharmaceutical …
(CRV), complemented by compatibility studies with a great variety of pharmaceutical …
[图书][B] La compleja interacción biológica y biopsicológica en la ciencia médica
LFGF Ruiz - 2024 - books.google.com
La labor del médico conlleva un profundo conocimiento de la compleja interacción
biológica y psicobiológica que ocurre en el organismo humano, además de lograr …
biológica y psicobiológica que ocurre en el organismo humano, además de lograr …
Données récentes sur l'hypertension endocrine
A Al-Salameh, R Cohen, P Chanson, PF Plouin - Annales d'endocrinologie, 2012 - Elsevier
Résumé L'hypertension endocrine est la cause la plus fréquente d'hypertension secondaire,
touchant près de 3% de la population. L'hyperaldostéronisme primaire et le …
touchant près de 3% de la population. L'hyperaldostéronisme primaire et le …